The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical activity of single-agent gemcitabine in a single-center series of 83 malignant pleural mesothelioma after failure of pemetrexed-based chemotherapy.
Federica Grosso
No relevant relationships to disclose
Annalisa Roveta
No relevant relationships to disclose
Daniela Degiovanni
No relevant relationships to disclose
Ezio Piccolini
No relevant relationships to disclose
Stefano Barbero
No relevant relationships to disclose
Francesco Musante
No relevant relationships to disclose
Gabriele Ferretti
No relevant relationships to disclose
Massimo Pastormerlo
No relevant relationships to disclose
Alberto Muzio
No relevant relationships to disclose
Mario Botta
No relevant relationships to disclose